Till Acker

Giessen, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reporting.

Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reporting.

Journal: Brain pathology (Zurich, Switzerland)

Published: March 13, 2026

Region-specific ups and downs in mitochondrial numerical densities during Alzheimer's disease progression: A pilot study in human brains.

Region-specific ups and downs in mitochondrial numerical densities during Alzheimer's disease progression: A pilot study in human brains.

Journal: Journal of Alzheimer's disease : JAD

Published: March 06, 2026

Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.

Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.

Journal: Acta neuropathologica

Published: February 21, 2026

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Journal: Nature communications

Published: January 09, 2026

Primary mismatch repair deficient glioma, IDH-wildtype and H3-wildtype: A giant cell tumor with potential for long-term survival occurring at all ages.

Primary mismatch repair deficient glioma, IDH-wildtype and H3-wildtype: A giant cell tumor with potential for long-term survival occurring at all ages.

Journal: Neuro-oncology

Published: December 15, 2025

Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all Ages.

Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all Ages.

Journal: Neuro-oncology

Published: December 15, 2025

Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.

Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.

Journal: Acta neuropathologica

Published: August 26, 2025

Hypoxia or tobacco-smoke exposure induce region-specific microvascular remodeling in the brain.

Hypoxia or tobacco-smoke exposure induce region-specific microvascular remodeling in the brain.

Journal: Scientific reports

Published: August 25, 2025

The prognostic impact of CDKN2A/B hemizygous deletions in meningioma.

The prognostic impact of CDKN2A/B hemizygous deletions in meningioma.

Journal: Neuro-oncology

Published: August 13, 2025

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Journal: Nature cancer

Published: July 26, 2025

Advancing sarcoma diagnostics with expanded DNA methylation-based classification.

Advancing sarcoma diagnostics with expanded DNA methylation-based classification.

Journal: medRxiv : the preprint server for health sciences

Published: July 09, 2025

Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries.

Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries.

Journal: Neuro-oncology

Published: June 24, 2025

Showing 1-12 of 93

Last Updated: 09/26/2026